Raphael Pharmaceutical (RAPH) Cash from Operations (2020 - 2025)
Raphael Pharmaceutical's (RAPH) quarterly Cash from Operations came in at 46000.0 in Q4 2025, up 174.19% year-on-year from 16776.47 in Q4 2024, and up 370.59% quarter-over-quarter from 17000.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Cash from Operations (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has disclosed Cash from Operations across 6 years of filings, most recently posting 46000.0 for Q4 2025.
- Cash from Operations for Q4 2025 came in at 46000.0, up 174.19% year-over-year; the trailing twelve-month figure through Dec 2025 was 210000.0 (up 60.53% YoY), and the FY2025 annual result was 210000.0, up 60.53% from the prior year.
- Cash from Operations came in at 46000.0 for Q4 2025 at Raphael Pharmaceutical, up from 17000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 46000.0 in Q4 2025 to a low of 704000.0 in Q4 2021.
- The 5-year median for Cash from Operations is 190500.0 (2024), against an average of 206150.0.
- Across the five-year window, Cash from Operations slumped 386.59% in 2023 and soared 174.19% in 2025, its largest moves.
- Raphael Pharmaceutical's Cash from Operations stood at 704000.0 in 2021, then surged by 60.65% to 277000.0 in 2022, then jumped by 68.23% to 88000.0 in 2023, then grew by 29.55% to 62000.0 in 2024, then surged by 174.19% to 46000.0 in 2025.
- The last three Cash from Operations figures came in at 46000.0 (Q4 2025), 17000.0 (Q3 2025), and 30000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | Raphael Pharmaceutical | - | - | - | 46,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46,000.00 |
| Dec 31, 2025 | 46,000.00 |
| Sep 30, 2025 | -17,000.00 |
| Sep 30, 2025 | -17,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Jun 30, 2025 | -30,000.00 |
| Mar 31, 2025 | -209,000.00 |
| Mar 31, 2025 | -209,000.00 |
| Dec 31, 2024 | -62,000.00 |
| Dec 31, 2024 | -62,000.00 |
| Sep 30, 2024 | -80,000.00 |
| Sep 30, 2024 | -80,000.00 |
| Jun 30, 2024 | -218,000.00 |
| Jun 30, 2024 | -218,000.00 |
| Mar 31, 2024 | -172,000.00 |
| Mar 31, 2024 | -172,000.00 |
| Dec 31, 2023 | -88,000.00 |
| Dec 31, 2023 | -88,000.00 |
| Sep 30, 2023 | -501,000.00 |
| Sep 30, 2023 | -501,000.00 |